The pathogenesis of human cytomegalovirus

A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus

(2014) Maria Grazia Revello et al.   NEW ENGLAND JOURNAL OF MEDICINE

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

(2014) Roy F. Chemaly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mitogen and Stress Activated Kinases Act Co-operatively with CREB during the Induction of Human Cytomegalovirus Immediate-Early Gene Expression from Latency

(2014) Verity G. Kew et al.   PLoS Pathogens

Cytomegalovirus in the Neonate: Immune Correlates of Infection and Protection

(2013) Mark R. Schleiss   Clinical & Developmental Immunology

Seropositivity and Higher Immunoglobulin G Antibody Levels Against Cytomegalovirus Are Associated With Mortality in the Population-Based European Prospective Investigation of Cancer–Norfolk Cohort

(2013) Effrossyni Gkrania-Klotsas et al.   CLINICAL INFECTIOUS DISEASES

Impact of human cytomegalovirus (CMV) infection on immune response to pandemic 2009 H1N1 influenza vaccine in healthy adults

(2013) Anna Wald et al.   JOURNAL OF MEDICAL VIROLOGY

CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

(2013) Francisco M. Marty et al.   NEW ENGLAND JOURNAL OF MEDICINE

The apparent paradox of maternal seropositivity as a risk factor for congenital cytomegalovirus infection: a population-based prediction model

(2013) Jutte J. C. de Vries et al.   REVIEWS IN MEDICAL VIROLOGY

Latency-Associated Degradation of the MRP1 Drug Transporter During Latent Human Cytomegalovirus Infection

(2013) M. P. Weekes et al.   SCIENCE

Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy

(2012) S. F. Atabani et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial

(2012) Mohamed A Kharfan-Dabaja et al.   LANCET INFECTIOUS DISEASES

Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation

(2012) Paul D Griffiths   LANCET INFECTIOUS DISEASES

Human Cytomegalovirus Encoded Homologs of Cytokines, Chemokines and their Receptors: Roles in Immunomodulation

(2012) Brian McSharry et al.   Viruses-Basel

Human cytomegalovirus entry into cells

(2012) Adam L Vanarsdall et al.   Current Opinion in Virology

Cytomegalovirus: pathogen, paradigm, and puzzle

(2011) Michael Boeckh et al.   JOURNAL OF CLINICAL INVESTIGATION

Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: A 20-year experience

(2011) Maria Grazia Revello et al.   JOURNAL OF CLINICAL VIROLOGY

Protein pUL128 of Human Cytomegalovirus Is Necessary for Monocyte Infection and Blocking of Migration

(2011) S. Straschewski et al.   JOURNAL OF VIROLOGY

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

(2011) Paul D Griffiths et al.   LANCET

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

(2011) Francisco M Marty et al.   LANCET INFECTIOUS DISEASES

Seropositivity to Cytomegalovirus, Inflammation, All-Cause and Cardiovascular Disease-Related Mortality in the United States

(2011) Amanda M. Simanek et al.   PLoS One

Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection

(2011) Michael J. Cannon et al.   REVIEWS IN MEDICAL VIROLOGY

Maribavir and human cytomegalovirus—what happened in the clinical trials and why might the drug have failed?

(2011) Francisco M Marty et al.   Current Opinion in Virology

BST2/Tetherin Enhances Entry of Human Cytomegalovirus

(2011) Kasinath Viswanathan et al.   PLoS Pathogens

Cellular and Viral Control over the Initial Events of Human Cytomegalovirus Experimental Latency in CD34+ Cells

(2010) R. T. Saffert et al.   JOURNAL OF VIROLOGY

CMV in critically ill patients: pathogen or bystander?

(2010) Ajit P. Limaye et al.   REVIEWS IN MEDICAL VIROLOGY

Human cytomegalovirus immunity and immune evasion

(2010) Sarah E. Jackson et al.   VIRUS RESEARCH

Successful Immunotherapy of HCMV Disease Using Virus-Specific T Cells Expanded from an Allogeneic Stem Cell Transplant Recipient

(2009) G. R. Hill et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system

(2009) Sara E. Oliver et al.   JOURNAL OF CLINICAL VIROLOGY

Human Cytomegalovirus Glycoprotein B Is Required for Virus Entry and Cell-to-Cell Spread but Not for Virion Attachment, Assembly, or Egress

(2009) M. K. Isaacson et al.   JOURNAL OF VIROLOGY

Vaccine Prevention of Maternal Cytomegalovirus Infection

(2009) Robert F. Pass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Feeling manipulated: cytomegalovirus immune manipulation

(2009) Mindy Miller-Kittrell et al.   Virology Journal

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study

(2008) D. J. Winston et al.   BLOOD

Cytomegalovirus seroprevalence and childhood sources of infection: A population-based study among pre-adolescents in the United States

(2008) Stephanie A.S. Staras et al.   JOURNAL OF CLINICAL VIROLOGY

Platelet-derived growth factor-α receptor activation is required for human cytomegalovirus infection

(2008) Liliana Soroceanu et al.   NATURE

Cytomegalovirus and human immunosenescence

(2008) Graham Pawelec et al.   REVIEWS IN MEDICAL VIROLOGY